LRI Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117K Sell
1,362
-392
-22% -$34.4K 0.01% 424
2026
Q1
$159K Sell
1,754
-154
-8% -$14.1K 0.01% 322
2025
Q4
$172K Buy
1,908
+303
+19% +$28.7K 0.01% 314
2025
Q3
$158K Buy
1,605
+67
+4% +$6.64K 0.01% 334
2025
Q2
$140K Buy
1,538
+444
+41% +$42.9K 0.01% 358
2025
Q1
$124K Buy
1,094
+248
+29% +$26.5K 0.01% 367
2024
Q4
$89.4K Sell
846
-248
-23% -$26.6K 0.01% 431
2024
Q3
$119K Buy
1,094
+579
+112% +$63.2K 0.01% 375
2024
Q2
$55.9K Hold
515
0.01% 466
2024
Q1
$68K Buy
+515
New +$64.3K 0.02% 243

Other funds holding ZBH

LRI Investments's ZBH Position: Q2 2026 in Review

LRI Investments reduced its Zimmer Biomet (ZBH) stake by 22% in Q2 2026, selling an estimated $34.4K and leaving 1,362 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #424.

LRI Investments first reported a position in ZBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $172K in Q4 2025. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • LRI Investments held 1,362 shares of Zimmer Biomet worth $117K as of Q2 2026.
  • LRI Investments sold 392 Zimmer Biomet shares in Q2 2026, an estimated $34.4K.
  • Zimmer Biomet made up 0.01% of LRI Investments's portfolio in Q2 2026, its #424 holding.
  • LRI Investments first reported a position in Zimmer Biomet in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Zimmer Biomet position peaked at $172K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.